1-5 of 5
Paul Smith, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)

Rakesh Popat, James D Cavenagh, MD, Roger G Owen, MD, Matthew Streetly, Stephen A Schey, MD, Mickey Koh, MD, Josephine Crowe, Michael F. Quinn, FRCPath, MB, MD MRCP, Shirley D'Sa, MD FRCP, FRCPath, Andres Virchis, Gordon Cook, MD PhD, Charles Crawley, Guy Pratt, Mark Cook, PhD FRCPath, Heather E. Oakervee, MBBS, BSc, MD MRCP, FRCPath, Nicholas Counsell, Toyin Adedayo, Alison Evans, Nivette Braganca, Paul Smith, MSc, Janet lyons-Lewis, Neil Rabin, Kwee L Yong, MBChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4745.
https://doi.org/10.1182/blood.V124.21.4745.4745
Published: 2014
Journal Articles

Risk of CNS Relapse with Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab Era: Results from the UK NCRI R-CHOP 14 v 21 Trial

Mary Gleeson, FRCPath, David Cunningham, FMedSci, Eliza A Hawkes, MD, Wendi Qian, PhD, Paul Smith, MSc, Nick Chadwick, Paul Mouncey, MSc, Andrew Jack, PhD, Christopher Pocock, MD PhD, Kirit M Ardeshna, MD FRCPath, John Radford, Andrew McMillan, PhD, John Davies, FRCPE, Deborah Turner, FRCPath, Anton Kruger, FRCPath, Peter W.M. Johnson, FRCP, Joanna Gambell, BSc, David C Linch, FMedSci
Journal: Blood
Blood (2014) 124 (21): 1723.
https://doi.org/10.1182/blood.V124.21.1723.1723
Published: 2014
Journal Articles

Prognostic Effect Of More Than 1 Extranodal Site Of Disease For Patients With Diffuse Large B Cell Lymphoma (DLBCL) In The Rituximab Era: Results From The UK NCRI R-CHOP 14 Versus 21 Trial

Mary Gleeson, FRCPath, Wendi Qian, PhD, David Cunningham, FMedSci, Eliza Hawkes, FRACP, Andrew Jack, PhD, Paul Smith, MSc, Paul Mouncey, MSc, Christopher Pocock, PhD, Kirit M Ardeshna, FRCPath, John Radford, MD, Andrew McMillan, FRCPath, John Davies, FRCPE, Deborah Turner, FRCPath, Anton Kruger, FRCPath, Peter Johnson, FRCP, Joanna Gambell, BSc, David Linch, FMedSci
Journal: Blood
Blood (2013) 122 (21): 4268.
https://doi.org/10.1182/blood.V122.21.4268.4268
Published: 2013
Journal Articles

Mabthera (Rituximab) Plus CVP Chemotherapy for First-Line Treatment of Stage III/IV Follicular Non-Hodgkin’s Lymphoma (NHL): Confirmed Efficacy with Longer Follow-Up.

Philippe Solal-Celigny, MD, Kevin Imrie, MD, Andrew Belch, MD, Katherine Sue Robinson, MD, David Cunningham, Antonio Rueda, MD, John Catalano, MD, Fritz Offner, Jan Walewski, MD, João Raposo, MD, Paul Smith, MSc, Robert Marcus, MD
Journal: Blood
Blood (2005) 106 (11): 350.
https://doi.org/10.1182/blood.V106.11.350.350
Published: 2005
Journal Articles

Improved Outcome Following Reduced Intensity Allogeneic Transplantation in Hodgkin’s Lymphoma Relapsing Post-Autologous Transplantation.

Kirsty J. Thomson, MD, Karl S. Peggs, MD, Paul Smith, MSc, Raj Chopra, MD, Jim Cavet, MD, Ann Hunter, MD, Anne Parker, MD, Ruth Pettengell, MD, Don Milligan, MD, Emma C. Morris, MD, Anthony H. Goldstone, MD, David C. Linch, MD, Stephen Mackinnon, MD
Journal: Blood
Blood (2005) 106 (11): 657.
https://doi.org/10.1182/blood.V106.11.657.657
Published: 2005